Literature DB >> 2292699

Neuronal ceroid-lipofuscinosis: preferential metabolic alterations in thalamus and posterior association cortex demonstrated by PET.

A G De Volder1, S Cirelli, T de Barsy, J M Brucher, A Bol, C Michel, A M Goffinet.   

Abstract

Regional brain glucose utilisation was investigated with positron emission tomography (PET) and fluorodeoxyglucose (FDG) in four siblings with neuronal ceroid-lipofuscinosis. A consistent pattern was found, namely a decrease of glucose utilisation in all grey structures but more marked at the level of the thalamus and posterior association cortex. The severity of metabolic anomalies was correlated with the degree of clinical impairment and with disease duration; they were the most severe in the oldest patient, who was also the most affected clinically, intermediate in two others, and minimal in the subject with the shortest period of development of the disease. These observations suggest that PET is useful for the definition of anatomical targets of metabolic diseases and for the investigation of their pathophysiology.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2292699      PMCID: PMC488316          DOI: 10.1136/jnnp.53.12.1063

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  17 in total

1.  Brain glucose metabolism in postanoxic syndrome. Positron emission tomographic study.

Authors:  A G DeVolder; A M Goffinet; A Bol; C Michel; T de Barsy; C Laterre
Journal:  Arch Neurol       Date:  1990-02

2.  Familial disorder of the central and peripheral nervous systems with particular cytoplasmic lamellated inclusions in peripheral nerves, muscle satellite cells, and blood capillaries.

Authors:  F M Tomé; P Brunet; M Fardeau; F Hentati; J Reix
Journal:  Acta Neuropathol       Date:  1985       Impact factor: 17.088

3.  Effect of piracetam on cerebral glucose metabolism in Alzheimer's disease as measured by positron emission tomography.

Authors:  W D Heiss; I Hebold; P Klinkhammer; P Ziffling; B Szelies; G Pawlik; K Herholz
Journal:  J Cereb Blood Flow Metab       Date:  1988-08       Impact factor: 6.200

Review 4.  Kufs' disease: a critical reappraisal.

Authors:  S F Berkovic; S Carpenter; F Andermann; E Andermann; L S Wolfe
Journal:  Brain       Date:  1988-02       Impact factor: 13.501

5.  Calculation of cerebral glucose phosphorylation from brain uptake of glucose analogs in vivo: a re-examination.

Authors:  A Gjedde
Journal:  Brain Res       Date:  1982-06       Impact factor: 3.252

6.  Adrenoleukodystrophy: imaging with CT, MRI, and PET.

Authors:  N D Volkow; L Patchell; M V Kulkarni; K Reed; M Simmons
Journal:  J Nucl Med       Date:  1987-04       Impact factor: 10.057

7.  Cerebral glucose utilization in pediatric neurological disorders determined by positron emission tomography.

Authors:  K Yanai; K Iinuma; T Matsuzawa; M Ito; S Miyabayashi; K Narisawa; T Ido; K Yamada; K Tada
Journal:  Eur J Nucl Med       Date:  1987

8.  Effects of thalamic stroke on energy metabolism of the cerebral cortex. A positron tomography study in man.

Authors:  J C Baron; R D'Antona; P Pantano; M Serdaru; Y Samson; M G Bousser
Journal:  Brain       Date:  1986-12       Impact factor: 13.501

9.  Familial occurrence of adult-type neuronal ceroid lipofuscinosis.

Authors:  M Tobo; Y Mitsuyama; K Ikari; K Itoi
Journal:  Arch Neurol       Date:  1984-10

10.  Atypical neuronal ceroid-lipofuscinosis.

Authors:  R S Greenwood; J S Nelson
Journal:  Neurology       Date:  1978-07       Impact factor: 9.910

View more
  6 in total

1.  FDG-PET assessment and metabolic patterns in Lafora disease.

Authors:  Lorenzo Muccioli; Andrea Farolfi; Federica Pondrelli; Giuseppe d'Orsi; Roberto Michelucci; Elena Freri; Laura Canafoglia; Laura Licchetta; Francesco Toni; Rachele Bonfiglioli; Simona Civollani; Cinzia Pettinato; Elisa Maietti; Giorgio Marotta; Stefano Fanti; Paolo Tinuper; Francesca Bisulli
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-12-19       Impact factor: 9.236

2.  [18F]fluorodopa PET shows striatal dopaminergic dysfunction in juvenile neuronal ceroid lipofuscinosis.

Authors:  H M Ruottinen; J O Rinne; M Haaparanta; O Solin; J Bergman; V J Oikonen; I Järvelä; P Santavuori
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-06       Impact factor: 10.154

Review 3.  Excess iron harms the brain: the syndromes of neurodegeneration with brain iron accumulation (NBIA).

Authors:  Susanne A Schneider; Kailash P Bhatia
Journal:  J Neural Transm (Vienna)       Date:  2012-12-02       Impact factor: 3.575

4.  Atp13a2-deficient mice exhibit neuronal ceroid lipofuscinosis, limited α-synuclein accumulation and age-dependent sensorimotor deficits.

Authors:  Patrick J Schultheis; Sheila M Fleming; Amy K Clippinger; Jada Lewis; Taiji Tsunemi; Benoit Giasson; Dennis W Dickson; Joseph R Mazzulli; Mark E Bardgett; Kristi L Haik; Osunde Ekhator; Anil Kumar Chava; John Howard; Matt Gannon; Elizabeth Hoffman; Yinhuai Chen; Vikram Prasad; Stephen C Linn; Rafael J Tamargo; Wendy Westbroek; Ellen Sidransky; Dimitri Krainc; Gary E Shull
Journal:  Hum Mol Genet       Date:  2013-02-07       Impact factor: 6.150

5.  Mutation of the parkinsonism gene ATP13A2 causes neuronal ceroid-lipofuscinosis.

Authors:  Jose Bras; Alain Verloes; Susanne A Schneider; Sara E Mole; Rita J Guerreiro
Journal:  Hum Mol Genet       Date:  2012-03-02       Impact factor: 6.150

6.  Genetics and Pathophysiology of Neurodegeneration with Brain Iron Accumulation (NBIA).

Authors:  Susanne A Schneider; Petr Dusek; John Hardy; Ana Westenberger; Joseph Jankovic; Kailash P Bhatia
Journal:  Curr Neuropharmacol       Date:  2013-01       Impact factor: 7.363

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.